⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 8, 2024

[Biological characteristics of triple negative breast cancer with low expression of HER2].

Jing Lian Ran Li Lili Yan Peili Bu Hongwei Wang Yanfeng Xi

View at Publisher

Ask AI

Bookmark

Share

Abstract

To investigate the biological characteristics of triple negative breast cancer (TNBC) with low expression of HER2 (HER2-low).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lian et al. (2024) studied this question.

synapsesocial.com/papers/68e590f7b6db64358752ccbe https://doi.org/10.3760/cma.j.cn112151-20240531-00361

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical Significance of HER2‐low Expression in Triple‐ negative Breast Cancer: A Retrospective Multicenter StudyCohort Study · 2025 · 2 citations
2Do all multi-peak LED light-curing units emit similar light outputs?Original Research · 2026 · 1 citations
3Exploring the spectrum of HER2 in non-metastatic triple negative breast cancer: from HER2-Null to HER2-low, including HER2-ultralow statusOriginal Research · 2026 · 1 citations
4Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer2025 · 10 citations
5Landscape of HER2-low breast cancer: Insights from a six-year study on incidence and clinicopathological characteristics.2024 · 3 citations

Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer2025
[Clinicopathological features of breast cancer with HER2 low expression: a real-world retrospective study].2024
Association between HER2 expression levels and sonographic features in triple-negative breast cancer2026